Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2019-04-01 (7 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CHARTRETTES (77590), Seine-et-Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE DE CHARTRETTES : revenue, balance sheet and financial ratios
SELARL PHARMACIE DE CHARTRETTES is a French company
founded 7 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CHARTRETTES (77590),
this company of category PME
shows in 2025 a net income positive of 86 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DE CHARTRETTES (SIREN 849107891)
Indicator
2025
2024
2023
2022
2021
2020
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
85 539 €
114 461 €
110 867 €
157 425 €
137 092 €
55 662 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, SELARL PHARMACIE DE CHARTRETTES generates positive net income of 86 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2025: 56 k€ -> 86 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
85 539 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 146%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 34%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
146.099%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
33.874%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DE CHARTRETTES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
2024
2025
Debt ratio
2280.435
790.107
384.161
269.469
193.615
146.099
Financial autonomy
3.377
9.613
18.033
23.081
28.561
33.874
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
146.12025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average
In 2025, the debt ratio of SELARL PHARMACIE DE CHART... (146.10) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
33.87%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average
In 2025, the financial autonomy of SELARL PHARMACIE DE CHART... (33.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 173.11. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
173.108
Liquidity indicators evolution SELARL PHARMACIE DE CHARTRETTES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2020
2021
2022
2023
2024
2025
Liquidity ratio
137.099
225.952
228.175
208.834
192.95
173.108
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquidity ratio
173.112025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Average-10 pts over 3 years
In 2025, the liquidity ratio of SELARL PHARMACIE DE CHART... (173.11) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of SELARL PHARMACIE DE CHARTRETTES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SELARL PHARMACIE DE CHARTRETTES is estimated at
1 358 797 €
(range 922 086€ - 2 132 139€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
922k€1358k€2132k€
1 358 797 €Range: 922 086€ - 2 132 139€
NAF 5 année 2025
Valuation method used
Net Income Multiple
85 539 €
×
15.9x
=1 358 797 €
Range: 922 086€ - 2 132 140€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DE CHARTRETTES with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DE CHARTRETTES
What is the revenue of SELARL PHARMACIE DE CHARTRETTES ?
The revenue of SELARL PHARMACIE DE CHARTRETTES is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE DE CHARTRETTES profitable?
Yes, SELARL PHARMACIE DE CHARTRETTES generated a net profit of 86 k€ in 2025.
Where is the headquarters of SELARL PHARMACIE DE CHARTRETTES ?
The headquarters of SELARL PHARMACIE DE CHARTRETTES is located in CHARTRETTES (77590), in the department Seine-et-Marne.
Where to find the tax return of SELARL PHARMACIE DE CHARTRETTES ?
The tax return of SELARL PHARMACIE DE CHARTRETTES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DE CHARTRETTES operate?
SELARL PHARMACIE DE CHARTRETTES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart